Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02414698Phase 4Terminated
Phase 4, randomised, open-label trial, sponsored by Montefiore Medical Center. Primary endpoint: 50% Reduction in Leg and Back Pain at 6 months. Started Jan 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02414698.